What Is AMP on a Drug Screen and What Does It Mean?

AMP is the abbreviation for amphetamines on a urine drug screen, and a positive result means the test detected substances in the amphetamine class above a preset threshold. That class is broader than most people expect, covering not just illicit street amphetamine or methamphetamine but also widely prescribed medications like Adderall and Vyvanse. Because the initial screen uses an antibody-based method that reacts to the general shape of the amphetamine molecule, it can also flag compounds that merely look similar, which is why a positive AMP result does not automatically mean someone used an illegal drug.

What the AMP Category Covers

Standard drug screening panels test for several drug classes at once. The most common workplace and clinical panels include amphetamines (AMP), cannabinoids (THC), opiates, cocaine metabolites, and phencyclidine (PCP), though expanded panels add benzodiazepines, barbiturates, and other categories.¹ Under the AMP umbrella, the test is looking for amphetamine itself, methamphetamine, and several related compounds including MDMA (ecstasy), MDA, and MDEA.² When you see “AMP positive” on a report, the test is saying that something in the urine looks like an amphetamine-type stimulant at a concentration above the cutoff. It is not yet telling you which specific substance triggered the result.

How the Initial Screen Works

The first test you encounter is almost always an immunoassay, a rapid technique that uses antibodies designed to bind to molecules shaped like amphetamines. These are the same type of tests used in point-of-care cups at clinics, emergency departments, and workplace testing sites.³ Immunoassays are fast and inexpensive, but they sacrifice precision for speed. The antibodies react strongly to amphetamine and methamphetamine, but they also cross-react with molecules that share a similar chemical backbone, even if those molecules are not true amphetamines. This is the root cause of most false positives on the AMP line.

These screening tests report results as positive or negative based on a cutoff concentration. For federally regulated workplace testing in the United States, the screening cutoff for amphetamines has historically been set at 1,000 ng/mL. Research has shown that this threshold is actually quite high; a single 5-mg dose of d-amphetamine often fails to produce a urine concentration above 1,000 ng/mL, meaning the test can miss low-level legitimate use.⁴ Other testing settings, especially clinical or pain-management programs, sometimes use lower cutoffs (around 250-500 ng/mL) to improve detection sensitivity.⁵ So the answer to “does my prescription show up?” depends partly on the dose you take and partly on which cutoff the lab is using.

Why AMP Can Come Back Positive When You Have Not Used Amphetamines

False positives on the AMP line are one of the most common problems in drug testing, and the list of everyday medications that can trigger one is surprisingly long. Over-the-counter nasal decongestants containing pseudoephedrine are well-documented culprits. Vicks inhalers, which contain levomethamphetamine (l-methamphetamine), can also light up the AMP screen.⁶ Among prescription medications, bupropion (sold as Wellbutrin for depression and as Zyban for smoking cessation) is a particularly notorious offender. In one hospital study, bupropion accounted for about 41% of all AMP-positive screens that failed to confirm on follow-up testing, making it the single most common cause of false positives for amphetamines in that setting.⁷

The mechanism behind the bupropion false positive is now well understood. Bupropion’s metabolites share enough structural similarity with amphetamine that immunoassay antibodies bind to them. Laboratory testing has confirmed that when bupropion metabolite concentrations exceed about 500 ng/mL in urine, certain immunoassay kits will return a positive amphetamine result, even though no amphetamine is present.⁸ Other medications that have been associated with false-positive AMP screens include labetalol (a blood pressure drug), trazodone (an antidepressant and sleep aid), chlorpromazine (an antipsychotic), and atomoxetine (a non-stimulant ADHD medication).⁶

If you are taking any of these medications and face a drug test, the most practical step is to disclose them before or immediately after the test. That disclosure allows the reviewing officer or physician to anticipate and investigate a false positive rather than treating the result at face value.

What Happens After a Positive Screen

A positive immunoassay screen is considered a presumptive result, not a definitive one. When the stakes matter, whether that is a job offer, a pain management contract, or a legal proceeding, the sample should go to a confirmation step using a more sophisticated instrument, typically liquid chromatography–tandem mass spectrometry (LC-MS/MS) or gas chromatography–mass spectrometry (GC-MS). These methods identify individual molecules by their exact mass and fragmentation pattern, giving far higher sensitivity and specificity than any immunoassay.⁹

Confirmation testing can do several things the initial screen cannot. It can tell you exactly which substance is present: amphetamine alone, methamphetamine with its amphetamine metabolite, MDMA, or none of the above. It can measure the precise concentration. And it uses a lower confirmation cutoff (often 250 ng/mL for amphetamine or methamphetamine in federally regulated programs) to catch cases that barely crossed the screening threshold.⁵ If the confirmation test does not find any actual amphetamine-class compound, the result is reported as negative, regardless of what the screen said. That is the point at which most bupropion and pseudoephedrine false positives are caught.

Prescription ADHD Medications and the AMP Result

If you take a prescribed amphetamine-based medication like Adderall (mixed amphetamine salts), Dexedrine (dexamphetamine), or Vyvanse (lisdexamfetamine), your AMP screen will likely come back positive, and the confirmation test will also be positive, because your body is genuinely excreting amphetamine. Vyvanse is a prodrug: after you swallow it, enzymes in your red blood cells cleave it into d-amphetamine, which is the active drug.¹⁰ About 42% of a Vyvanse dose ends up excreted in urine as d-amphetamine.¹¹ So the test is working exactly as designed. The question is not whether the amphetamine is there; it is whether its presence can be explained by a legitimate prescription.

This is where the medical review process becomes important. In federally regulated workplace testing, a positive confirmed result goes to a Medical Review Officer (MRO), a physician trained in toxicology interpretation. The MRO contacts the donor to ask about prescriptions and medical history before issuing a final report. A large workplace testing study found that about 63% of confirmed amphetamine-positive samples were ultimately verified by the MRO as being due to a medical prescription, not illicit use.¹² That is a striking number: nearly two-thirds of positive AMP results in the workplace turned out to be legitimate. Without MRO review, those people would all have been flagged as drug users.

Chiral Testing to Tell Prescription From Street Amphetamine

Amphetamine comes in two mirror-image forms: d-amphetamine and l-amphetamine. They have the same chemical formula but are mirror images at the molecular level, like left and right hands. This distinction turns out to be medically and forensically useful. Prescription ADHD medications that are currently approved in many countries contain only d-amphetamine or convert exclusively to d-amphetamine (as Vyvanse does). Street-manufactured amphetamine, by contrast, is typically a racemic mixture containing roughly equal amounts of the d- and l- forms.¹³

Specialized chiral analysis using liquid chromatography–tandem mass spectrometry can separate and measure the two forms independently.¹⁴ If a urine sample contains only d-amphetamine with no l-amphetamine, that is consistent with a legitimate prescription. If both forms appear in roughly equal proportions, illicit amphetamine use is strongly suspected. One large evaluation of over 24,000 chiral test results collected over a decade confirmed that this approach reliably distinguished ADHD medication compliance from illicit drug use.¹³ It is worth noting that chiral testing is not routine in most standard workplace or clinical screens. It tends to be ordered specifically when someone claims a prescription but the pattern needs verification, or in pain management programs where distinguishing compliance from diversion matters.

There is an interesting complication with Vicks inhalers. The active ingredient, levomethamphetamine, is the l- form of methamphetamine, which your body can metabolize into l-amphetamine. So a person who uses a Vicks inhaler and has a positive AMP screen will show l-amphetamine or l-methamphetamine on chiral analysis, a pattern that actually looks different from both prescription stimulants (which produce d-amphetamine) and street drugs (which produce both forms). The proportion of each isomer tells the story.¹⁵

Factors That Affect How Long AMP Shows Up

The detection window for amphetamines in urine is commonly quoted as one to three days after last use for most people, but that window can shift considerably depending on urine pH. Amphetamine is a basic (alkaline) molecule, and its excretion is heavily influenced by how acidic or alkaline your urine is. When urine is more acidic, amphetamine becomes ionized in the kidney tubules, which prevents it from being reabsorbed back into the bloodstream. More of the drug washes out in the urine. When urine is more alkaline, the opposite happens: more amphetamine gets reabsorbed, and less appears in the urine sample.¹⁶

Higher urine flow also increases excretion.⁴ This means that someone who is well-hydrated and has naturally acidic urine could clear the drug faster than someone who is dehydrated or has alkaline urine. The practical takeaway is that detection times are approximations, not guarantees. A single dose might be cleared in under 24 hours in one person but remain detectable for three days in another, depending on these variables.

Attempts to Beat the Test

Because drug testing carries real consequences for employment, child custody, pain management, and criminal justice, attempts to manipulate results are common. The most frequently used strategies include diluting the urine sample by drinking large volumes of water beforehand, adding chemical adulterants to the sample cup, and substituting someone else’s urine or a synthetic urine product.¹⁷

Modern testing protocols have countermeasures for all of these. Labs routinely check urine temperature immediately after collection (a cold sample suggests substitution), measure creatinine and specific gravity (abnormally low values indicate dilution), and test for common adulterants like bleach, pyridinium chlorochromate, and surfactants. A sample flagged as dilute usually results in a retest under observed conditions. A sample identified as adulterated or substituted is treated as a refusal to test in most regulated programs, which can carry the same consequences as a positive result.

When AMP Shows Up in Non-Urine Specimens

While urine remains the standard specimen for most drug testing programs, federal guidelines also allow testing of oral fluid, hair, and sweat patches for amphetamines.² Each matrix has different detection characteristics. Oral fluid testing is gaining popularity for workplace testing because the collection can be directly observed (making substitution virtually impossible) and the detection window is shorter, roughly 24 to 48 hours, which more closely reflects recent impairment rather than past use.

Sweat patches, which are worn on the skin for days to weeks, collect drugs as they are excreted through perspiration. In a controlled study where participants received known doses of methamphetamine, weekly sweat patches detected the drug in the vast majority of collection periods, with amphetamine appearing as a metabolite alongside methamphetamine.¹⁸ Hair testing offers the longest detection window, potentially several months depending on hair length, but is better suited for establishing patterns of use rather than detecting a single recent exposure. The choice of specimen type can change what an AMP result means practically: a positive oral fluid sample points to use within the last day or two, while a positive hair sample may reflect exposure that occurred weeks ago.

How Amphetamines Produce Their Effects

Understanding why amphetamines are tested for in the first place requires a brief look at what they do in the brain. Amphetamines increase levels of dopamine, norepinephrine, and serotonin in the spaces between nerve cells. They accomplish this by entering nerve terminals through the same transporters that normally recycle these chemical messengers, then reversing the direction of the transporter so that neurotransmitters flow out of the cell instead of being pulled back in. They also dump stored neurotransmitter from internal compartments within the nerve cell, flooding the synapse.¹⁹ At therapeutic doses, this mechanism improves attention and executive function in people with ADHD. At higher doses or in people without ADHD, it produces euphoria, heightened alertness, decreased appetite, and increased heart rate and blood pressure, all of which carry abuse and safety risks that make routine testing for the drug class medically and legally relevant.

Practical Steps if You Get an Unexpected AMP Positive

If you see a positive AMP result on a drug screen and you have not used any amphetamine-type drug, the first thing to do is stay calm. Initial immunoassay screens have a known false-positive rate, and you have a right to confirmatory testing. Review your medication list carefully. Bupropion, pseudoephedrine-containing cold medicines, Vicks inhalers, trazodone, and several other legitimate medications are documented causes. Bring your prescription bottles or pharmacy records to the follow-up interview if one is required.

In federally regulated testing, the MRO step is mandatory, and the MRO is specifically trained to distinguish false positives and prescription use from illicit consumption before a result is finalized.¹² Not all testing contexts include MRO review, however. Emergency department screens, for instance, are often used for clinical decision-making and may not go through a formal review process. In those situations, it falls to the treating physician to interpret the result in light of what medications the patient reports. If you feel a clinical decision is being made based on a false positive, ask for confirmation testing by mass spectrometry.

For people who take a prescribed stimulant for ADHD and know the AMP line will be positive, documentation is straightforward. Have your prescriber’s contact information ready and keep a record of your prescription fill dates. The confirmation test and MRO review will verify that the amphetamine in your sample is consistent with your prescribed medication, and if needed, chiral testing can confirm it further.